97 related articles for article (PubMed ID: 2428168)
1. The cellular tumour antigen p53: evidence for transformation-related, immunological variants of p53.
Milner J; Cook A
Virology; 1986 Oct; 154(1):21-30. PubMed ID: 2428168
[TBL] [Abstract][Full Text] [Related]
2. Evidence that immunological variants of p53 represent alternative protein conformations.
Gamble J; Milner J
Virology; 1988 Feb; 162(2):452-8. PubMed ID: 2448954
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody analysis of p53 expression in normal and transformed cells.
Yewdell JW; Gannon JV; Lane DP
J Virol; 1986 Aug; 59(2):444-52. PubMed ID: 2426467
[TBL] [Abstract][Full Text] [Related]
4. Variation in antigenic determinants of p53 transformation-related protein obtained from various species.
Rotter V; Friedman H; Katz A; Zerivitz K; Wolf D
J Immunol; 1983 Jul; 131(1):329-33. PubMed ID: 6190914
[TBL] [Abstract][Full Text] [Related]
5. Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule.
Wolf D; Harris N; Goldfinger N; Rotter V
Mol Cell Biol; 1985 Jan; 5(1):127-32. PubMed ID: 2580227
[TBL] [Abstract][Full Text] [Related]
6. Immunologically distinct p53 molecules generated by alternative splicing.
Arai N; Nomura D; Yokota K; Wolf D; Brill E; Shohat O; Rotter V
Mol Cell Biol; 1986 Sep; 6(9):3232-9. PubMed ID: 3023970
[TBL] [Abstract][Full Text] [Related]
7. Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein.
Milner J; Watson JV
Oncogene; 1990 Nov; 5(11):1683-90. PubMed ID: 2176282
[TBL] [Abstract][Full Text] [Related]
8. [Two immunologically differing forms of p53 oncoprotein from B-lymphocytes of mice are coded with identical mRNA].
Chumakov PM; Jenkins JR; Milner R
Mol Gen Mikrobiol Virusol; 1989 Aug; (8):14-6. PubMed ID: 2478880
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the in vitro interaction between SV40 T antigen and p53: mapping the p53 binding site.
Schmieg FI; Simmons DT
Virology; 1988 May; 164(1):132-40. PubMed ID: 2834865
[TBL] [Abstract][Full Text] [Related]
10. Evidence for allosteric variants of wild-type p53, a tumour suppressor protein.
Cook A; Milner J
Br J Cancer; 1990 Apr; 61(4):548-52. PubMed ID: 2139577
[TBL] [Abstract][Full Text] [Related]
11. The transformation-related p53 protein: a potential regulator of cell proliferation.
Mercer WE; Baserga R
Prog Clin Biol Res; 1985; 177():171-91. PubMed ID: 2409558
[No Abstract] [Full Text] [Related]
12. Visualisation, by immunocytochemistry, of p53 at the plasma membrane of both nontransformed and SV40-transformed cells.
Milner J; Cook A
Virology; 1986 Apr; 150(1):265-9. PubMed ID: 3006339
[TBL] [Abstract][Full Text] [Related]
13. Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein.
Crawford LV; Pim DC; Gurney EG; Goodfellow P; Taylor-Papadimitriou J
Proc Natl Acad Sci U S A; 1981 Jan; 78(1):41-5. PubMed ID: 6264441
[TBL] [Abstract][Full Text] [Related]
14. Precise epitope mapping of the murine transformation-associated protein, p53.
Wade-Evans A; Jenkins JR
EMBO J; 1985 Mar; 4(3):699-706. PubMed ID: 2408882
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells.
Reihsaus E; Kohler M; Kraiss S; Oren M; Montenarh M
Oncogene; 1990 Jan; 5(1):137-45. PubMed ID: 2157179
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human p53 antigens employing primate specific monoclonal antibodies.
Thomas R; Kaplan L; Reich N; Lane DP; Levine AJ
Virology; 1983 Dec; 131(2):502-17. PubMed ID: 6318442
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in distribution and content of p53 in SV40-transformed mouse fibroblasts.
Davis D; Wynford-Thomas D
Exp Cell Res; 1986 Sep; 166(1):94-102. PubMed ID: 3017740
[TBL] [Abstract][Full Text] [Related]
18. Transformation by simian virus 40 does not involve the mutational activation of p53 to an oncogenic form.
Lin JY; Simmons DT
Virology; 1990 May; 176(1):302-5. PubMed ID: 2158695
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.
Olson DC; Marechal V; Momand J; Chen J; Romocki C; Levine AJ
Oncogene; 1993 Sep; 8(9):2353-60. PubMed ID: 7689721
[TBL] [Abstract][Full Text] [Related]
20. A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40.
Milner J; Cook A; Sheldon M
Oncogene; 1987; 1(4):453-5. PubMed ID: 3330789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
